Embleema

Active (privatesale)
Own your medical & wearable data with Blockchain, opt-in to research, be compensated.

Whitepaper Project Demo

NOT YET ANALYZED

Sale Ends in

52Days 05Hours 35Minutes 20Seconds

Pre-Sale: 10 Oct 2018 - 31 Jan 2019
Main Sale: -

Token Price

1 RWD = 0.2 USD

Symbol
RWD
Platform
Ethereum
Type
ERC20
Decimals
18
Total Supply
500,000,000 RWD
For Sale
150,000,000 RWD
Softcap
3,000,000 USD
Hardcap
30,000,000 USD
Min. Investment
N/A
Max. Investment
N/A
Whitelist
YES
KYC
YES
Accepts
ETH, BTC, BCH, Fiat
Incorporated in
FRANCE
Restricted in
The Embleema Ambassador Program and Token sale are not open to residents and citizens of the USA, P.R. CHINA, CANADA, NEW ZEALAND, NORTH KOREA and any country within the list of non-cooperative countries from the TATF. We will be manually reviewing every Embleema’s Ambassador Program submissions.
Tokens Distribution
48% Compensation of Data Owners storing Health Records
30% subscribers of the Founder’s token sale
15% Embleema Founders & Advisors
7% Marketing & Community Development Fund
Funds Allocation
29% Service Delivery
25% Sales & Marketing
19% Product Development
14% Business Operations & Support
13% Management

About Embleema Project

Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.

We are a group of healthcare and technology veterans building it using cutting-edge technologies such as Blockchain and HL7 pharmaceutical industry standards. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier) and a full support from the medical research community, the pharmaceutical industry and patient associations.

Embleema Inc. was founded in 2017 by Robert Chu, an industry veteran with 20+ years of experience and a distinguished career at IBM Corp. and IQVIA, the global leader in health data and clinical research. He has been joined by other digital health figures such as Alexis Normand, VP of Withings, Pr. John Halamka, MD and Professor at Harvard Medical School, CIO of Beth Isreal Deaconess, Adel B. Al-Saleh, CEO of T-Systems and Frederic Duchesne, CEO of Pierre Fabre Pharmaceuticals !

By participating to Embleema’s community and ICO, you will be a pioneer in a new era of blockchain-based medical research. Join us !

Team Members
Robert CHU
CEO
Alexis Normand
Head of Cosortium
Nicolas Schmidt
CPO
Lorenzo Nardiello
Media Manager
Pradeep Sreekanthan
CDO
Vincent Galand
Opertions Manager
Atakan Seçkin
User Experience Advisor
Pascal Becache
Business Development Executive
Prashant Khambekar, PhD
Chief Blockchain Development Executive
Advisors
Frederic Duchesne, Pharm.D.
CEO of Pierre Fabre Pharmaceuticals
Vahan Simonyan, PhD
Chief Scientist - WHISE-Embleema Health Blockchain Consortium
Pr. John Halamka, MD
Professor of Innovation at Harvard Medical School
Adel Al-Saleh
CEO of T-Systems and Board Member of Deutsche Telekom
Bernard Gilly, PhD
CEO at GenSight Biologics & Chairman at iBionext
Partners
Servier Laboratoire
Pierre Fabre Laboiratoire
Bonus Details
Ambassador program
25%
Sale Commission (Aff/Ref)
25%
Bounty Details
Total Budget =
Campaign Share

Product

Data
Result
Product Differentiation
%
Blockchain Utilization
%
Whitepaper Presentation
%
Roadmap
%
MVP/Prototype
%
%

Business

Data
Result
Valuation
%
Market Potential
%
Competition
%
Legal
%
%

Token

Data
Result
Token Usage
%
Smart Contract
%
Fundraising Goals
%
Token Allocation
%
Funds Usage
%
%

Team

Data
Result
Background of Management Team
%
Team LinkedIn Profiles
%
Team KYC
%
Quality of Advisors
%
Quality of Partners
%
%

Community

Data
Result
Size of Community
%
Social Activity
%
Marketing
%
Support
%
%
0
Rating
Investor (0 votes) {{ reviewsOverall }} / 5
What investor say... Leave your rating
Order by:

Be the first to leave a review.

User Avatar User Avatar
Verified
{{{ review.rating_title }}}
{{{review.rating_comment | nl2br}}}

Show more
{{ pageNumber+1 }}
Leave your rating